1. Home
  2. GBIO vs SIDU Comparison

GBIO vs SIDU Comparison

Compare GBIO & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • SIDU
  • Stock Information
  • Founded
  • GBIO 2016
  • SIDU 2012
  • Country
  • GBIO United States
  • SIDU United States
  • Employees
  • GBIO N/A
  • SIDU N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • GBIO Health Care
  • SIDU Telecommunications
  • Exchange
  • GBIO Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • GBIO 29.2M
  • SIDU 30.0M
  • IPO Year
  • GBIO 2020
  • SIDU 2021
  • Fundamental
  • Price
  • GBIO $0.35
  • SIDU $1.76
  • Analyst Decision
  • GBIO Strong Buy
  • SIDU
  • Analyst Count
  • GBIO 4
  • SIDU 0
  • Target Price
  • GBIO $7.33
  • SIDU N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • SIDU 617.6K
  • Earning Date
  • GBIO 08-06-2025
  • SIDU 08-18-2025
  • Dividend Yield
  • GBIO N/A
  • SIDU N/A
  • EPS Growth
  • GBIO N/A
  • SIDU N/A
  • EPS
  • GBIO N/A
  • SIDU N/A
  • Revenue
  • GBIO $24,556,000.00
  • SIDU $3,860,985.00
  • Revenue This Year
  • GBIO N/A
  • SIDU $144.49
  • Revenue Next Year
  • GBIO N/A
  • SIDU N/A
  • P/E Ratio
  • GBIO N/A
  • SIDU N/A
  • Revenue Growth
  • GBIO 146.47
  • SIDU N/A
  • 52 Week Low
  • GBIO $0.30
  • SIDU $1.14
  • 52 Week High
  • GBIO $3.65
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 48.05
  • SIDU 57.36
  • Support Level
  • GBIO $0.32
  • SIDU $1.64
  • Resistance Level
  • GBIO $0.36
  • SIDU $1.80
  • Average True Range (ATR)
  • GBIO 0.03
  • SIDU 0.12
  • MACD
  • GBIO -0.00
  • SIDU 0.01
  • Stochastic Oscillator
  • GBIO 48.09
  • SIDU 81.82

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: